References
- AbbateMKalluriRCornaDExperimental Goodpasture’s syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagenKidney Int199854155015619844131
- KettritzRAutoimmunity in kidney diseasesScand J Clin Lab Invest Suppl20082419910318569975
- BoschXFontJThe pulmonary-renal syndrome: A poorly understood clinicopathologic conditionLupus1999825826210413202
- DuYFuYMohanCExperimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritisArch Immunol Ther Exp (Warsz)200856314018250969
- XieCRahmanZSXieSStrain distribution pattern of immune nephritis – a follow-up studyInt Immunol20082071972818381352
- LiQZZhouJYangRThe lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritisGenes Immun20091050350819262577
- DesvergneBWahliWPeroxisome proliferator-activated receptors: Nuclear control of metabolismEndocr Rev19992064968810529898
- NestoRWBellDBonowROThiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association107Circulation200310829412948
- YangMParizaMWCookMEDietary conjugated linoleic acid protects against end stage disease of systemic lupus erythematosus in the NZB/W F1 mouseImmunopharmacol Immunotoxicol20002243344910946824
- YangXYWangLHChenTActivation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFATJ Biol Chem20002754541454410671476
- BergamoPLuongoDMauranoFMazzarellaGStefanileRRossiMConjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Fas(lpr) miceJ Lipid Res2006472382239116877747
- Venegas-PontMSartori-ValinottiJCMaricCRosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosusAm J Physiol Regul Integr Comp Physiol2009296R1282128919193937
- AprahamianTBonegioRGRichezCThe peroxisome proliferator- activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinJ Immunol200918234034619109165
- MangelsdorfDJEvansRMThe RXR heterodimers and orphan receptorsCell1995838418508521508
- SpiegelmanBMPPAR gamma in monocytes: Less pain, any gainCell1998931531559568708
- MansenAGuardiola-DiazHRafterJBrantingCGustafssonJAExpression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosaBiochem Biophys Res Commun19962228448518651933
- SchoonjansKMartinGStaelsBAuwerxJPeroxisome proliferator-activated receptors, orphans with ligands and functionsCurr Opin Lipidol199781591669211064
- FajasLFruchartJCAuwerxJPPAR gamma3 mRNA: A distinct PPARgamma mRNA subtype transcribed from an independent promoterFEBS Lett199843855609821958
- BraissantOFoufelleFScottoCDaucaMWahliWDifferential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult ratEndocrinology19961373543668536636
- CuiYMiyoshiKClaudioELoss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertilityJ Biol Chem2002277178301783511884400
- AdachiMKurotaniRMorimuraKPeroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseGut2006551104111316547072
- GuriAJMohapatraSKHorneWT2ndHontecillasRBassaganya-RieraJThe role of T cell PPAR gamma in mice with experimental inflammatory bowel diseaseBMC Gastroenterol2010106020537136
- MohapatraSKGuriAJClimentMImmunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel diseasePLoS One.20105e1021520422041
- AkiyamaTESakaiSLambertGConditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol effluxMol Cell Biol2002222607261911909955
- Bassaganya-RieraJReynoldsKMartino-CattSActivation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel diseaseGastroenterology200412777779115362034
- HontecillasRBassaganya-RieraJPeroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitisJ Immunol20071782940294917312139
- GuriAJHontecillasRFerrerGLoss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissueJ Nutr Biochem20081921622817618105
- EvansNPMisyakSASchmelzEMGuriAJHontecillasRBassaganya-RieraJConjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgammaJ Nutr201014051552120089779
- AhmedSAGogalRMJrWalshJEA new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assayJ Immunol Methods19941702112248157999
- SekineHReillyCMMolanoIDComplement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr miceJ Immunol20011666444645111342671
- XieCSharmaRWangHZhouXJMohanCStrain distribution pattern of susceptibility to immune-mediated nephritisJ Immunol20041725047505515067087
- MalurAMcCoyAJArceSDeletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory responseJ Immunol20091825816582219380830
- WohlfertEANicholsFCNeviusEClarkRBPeroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: Enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanismsJ Immunol20071784129413517371968
- LavinskyRMJepsenKHeinzelTDiverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexesProc Natl Acad Sci U S A199895292029259501191
- RicoteMHuangJFajasLExpression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoproteinProc Natl Acad Sci U S A199895761476199636198
- FuYDuYMohanCExperimental anti-GBM disease as a tool for studying spontaneous lupus nephritisClin Immunol200712410911817640604
- ReillyCMThomasMGogalRJrThe histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 miceJ Autoimmun20083112313018650065
- AbdelrahmanMSivarajahAThiemermannCBeneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shockCardiovasc Res20056577278115721857
- WanSXiaCMorelLIL-6 produced by dendritic cells from lupusprone mice inhibits CD4+CD25+ T cell regulatory functionsJ Immunol200717827127917182564
- ReillyCMOatesJCCookJAMorrowJDHalushkaPVGilkesonGSInhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J(2) and proliferator activation receptor-gamma agonistsJ Immunol20001641498150410640767
- NamgaladzeDMorbitzerDvon KnethenABruneBPhospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptorsArterioscler Thromb Vasc Biol20103031332019948841
- BorniquelSJanssonEAColeMPFreemanBALundbergJONitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel diseaseFree Radic Biol Med20104849950519932165